Mayo Clinic

Investigators identified mutation, expression, and methylation differences in colorectal polyps from individuals with or without colorectal cancer.

The partners are developing and optimizing an algorithm that assesses the likelihood of a patient's cancer progressing to metastasis.

Mayo Clinic is taking an ownership stake in sequencing startup Veritas Genetics as it integrates genomics expertise into the myGenome WGS platform.

Convince Him

One Mayo Clinic doctor isn't sure of the value of genome sequencing, NPR reports.

The Mayo Clinic will apply PathoQuest's next-generation sequencing-based iDtect Blood test in a study to identify febrile neutropenia in patients.

Research teams documented mosaic mutations during brain development, as well as rising somatic mutations in aging brains or brains affected by neurodegenerative disease.

This Week in PLOS

In PLOS this week: de novo mutations in epileptic encephalopathy, sequencing analysis of aromatic rice, and more.

A tumor sequencing study suggests the retention or deletion of interstitial genes within the TMPRSS2-ERG gene fusion may coincide with prostate cancer progression.

The company recently released the MGISEQ-2000, MGISEQ-200, and MGIFLP sequencing platforms, as well as the MGIUS-R3 robotic ultrasound system.

Early users' experience engaging with the study protocol via the newly launched JoinAllofUs.org reveals areas that need refinement ahead of a full launch next year.

Pages

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.